High Lantern Group’s Post

🎖️ Veterans Affairs Prepares for MDMA’s Potential FDA Approval 👍 The VA is setting up a Psychedelic Medicine Integrated Project Team to provide strategic direction for the deployment of psychedelic medicine within the Veterans Health Administration. This includes advising the VA Under Secretary for Health, Shereef Elnahal. Dr. Elnahal emphasized the necessity for the VA to be ready for an "overwhelming demand" for MDMA-assisted therapy, anticipating approval as early as August. He stressed the superior potential of MDMA for PTSD compared to current treatments based on preliminary results. "The evidence-based therapies that we have, while they help, pale in comparison if we are able to replicate the scale seen in the preliminary results we have seen in psychedelics, especially MDMA for PTSD," Dr. Elnahal said. If MDMA receives FDA approval, it won't be as simple as popping a pill. Treatment involves controlled doses administered in a supervised setting, potentially lasting several hours. This necessitates adequate infrastructure and trained professionals to manage the therapy sessions. The VA is proactively working on ensuring these resources are in place to meet the expected high demand. #mdma #psychedelictherapy #veteranshealth #mentalhealth #PTSD #FDA #MDMAtherapy Full article in the comments!

Unlocking Hope: The Powerful Impact of MOUD Key Takeaways MOUD includes FDA-approved medications like methadone, buprenorphine, and naltrexone to treat opioid use disorder (OUD). MOUD treatment can reduce withdrawal symptoms, prevent overdose, and support long-term recovery. Integrating MOUD with behavioral therapies enhances treatment outcomes. MOUD is available through various opioid treatment programs and primary care providers. Access to MOUD is crucial for […] The post Unlocking Hope: The Powerful Impact of MOUD appeared first on Virtue Recovery Houston. https://lnkd.in/gQJ4SGSh

"Why should you consider treating TMD patients? While it may seem like an unfamiliar topic, TMD (Temporomandibular Disorder) is a significant chronic condition. It often begins as acute episodes and can evolve into persistent, decades-long chronic pain. This course is an opportunity to specialize and be at the forefront of a field that many professionals overlook. You might wonder, 'Why choose this course over others? There is an increasing demand for TMD specialists. Patients are out there! TMD is the second most common chronic disorder after lower back pain. By taking this course on December 2-3 in Reading, UK, and securing your spot with just a £100 deposit, you'll be on your way to making a real difference in the lives of TMD patients. Join the ranks of practitioners who understand how to stand out among their peers. Don't miss this chance to specialize in a field with tremendous potential. Abilitee - Delivering international courses for UK healthcare professionals.

Why MDMA versus other compounds in the FDA approval process? MDMA’s research trajectory has uniquely positioned it for early approval compared to other compounds like psilocybin. MDMA was the first to receive breakthrough therapy designation in 2017, slightly ahead of psilocybin in 2018, placing it at the forefront of the regulatory review queue. Follow our page Texans for Greater Mental Health for more clips from this conversation with Logan Davidson and Aaron Buzali about the recent FDA advisory hearing on MDMA for PTSD as we work toward a future where these incredible medicines are accessible to all who need them. 🧠💫 ______ #fda #psychedelictherapy #texas #psychedelicresearch

Amazed and heartened by how all groups, from industry, to researchers, and individual practitioners are coming together to address needs of patients with opioid dependence at #aatod2024 Excited to cover the meeting and learn the latest trends and science! https://lnkd.in/g7asD35m

Professionalism, which is central to science and medicine, can be shoved aside by a "move fast and break things" culture. The (paywalled) story below describes how MDMA "true believers" within Lycos' leadership took short cuts in certain aspects of the clinical trial process. The main victims here are PTSD patients who might benefit from MDMA, but now will have to wait a lot longer for FDA approval. #ethicalhealthcare #hippocraticcapitalism #clinicaltrials #mdma #ptsd

It was a very honor and a source of pride to have started my experience in NEURIMPULSE srl partecipating in Cadaverlab in order to develop new approaches and techniques about #PeripheralNerveStimulation! #PNS #NEURIMPULSE

Unlocking Hope: The Powerful Impact of MOUD Key Takeaways MOUD includes FDA-approved medications like methadone, buprenorphine, and naltrexone to treat opioid use disorder (OUD). MOUD treatment can reduce withdrawal symptoms, prevent overdose, and support long-term recovery. Integrating MOUD with behavioral therapies enhances treatment outcomes. MOUD is available through various opioid treatment programs and primary care providers. Access to MOUD is crucial for […] The post Unlocking Hope: The Powerful Impact of MOUD appeared first on Virtue Recovery Houston. https://lnkd.in/gQJ4SGSh

For the first time in decades, new approaches for treating PTSD and mental health conditions are coming to market, in the form of psychedelic drug therapies. Yet as discussed in the 2024 Syneos Health Trends report, the implementation pathway for novel treatments is strewn with hurdles—not least, the need to persuade payers that the therapies deliver value to patients, families, health systems and society. Read More Now: https://lnkd.in/ekYv3aNs

"Why should you consider treating TMD patients? While it may seem like an unfamiliar topic, TMD (Temporomandibular Disorder) is a significant chronic condition. It often begins as acute episodes and can evolve into persistent, decades-long chronic pain. This course is an opportunity to specialize and be at the forefront of a field that many professionals overlook. You might wonder, 'Why choose this course over others? There is an increasing demand for TMD specialists. Patients are out there! TMD is the second most common chronic disorder after lower back pain. By taking this course on December 2-3 in Reading, UK, and securing your spot with just a £100 deposit, you'll be on your way to making a real difference in the lives of TMD patients. Join the ranks of practitioners who understand how to stand out among their peers. Don't miss this chance to specialize in a field with tremendous potential. Abilitee - Delivering international courses for UK healthcare professionals.